Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation
Open Access
- 12 April 2019
- Vol. 11 (4), 527
- https://doi.org/10.3390/cancers11040527
Abstract
It is well-known that human epidermal growth factor receptor 2 (HER2) is critical for breast cancer (BC) development and progression. Several studies have revealed the role of the ubiquitin/proteasome system (UPS) in cancer. In this study, we investigated the expression level of Proteasome 26S subunit, non-ATPase 3 (PSMD3) in BC using BC cell lines, human BC tissue samples, Oncomine, and TCGA databases and studied the PSMD3-HER2 protein interaction. PSMD3 was upregulated in BC, particularly in the HER2+ subtype. PSMD3 immunostaining was detected in the cytoplasm and nucleus of BC tumor tissues. Strong interaction between PSMD3 and HER2 at the protein level was observed. Knockdown of PSMD3 significantly impaired the stability of HER2, inhibited BC cell proliferation and colony formation, and induced cell apoptosis. Ubiquitination process was strongly enhanced after knockdown of PSMD3 in association with decreased HER2 level. Accumulation and Localization of LAMP-1 in the cell membrane with decreased HER2 immunostaining was observed after knockdown of PSMD3. High expression level of PSMD3 was associated with HER2 expression (p < 0.001), tumor size (p < 0.001), and clinical stage (p = 0.036). High expression level of PSMD3 predicted a short overall survival (OS), particularly for HER2+. Overall, we provide a novel function for PSMD3 in stabilizing HER2 from degradation in HER2+ BC, which suggests that PSMD3 is a novel target for HER2+ BC.Keywords
Funding Information
- Ministry of Health and Welfare (MOHW107-TDU-B-212-114014)
- Ministry of Science and Technology, Taiwan (MOST105-2320-B-038-053-MY3, MOST106-2320-B-038-046,MOST106-2314-B-038-053-MY3 ,MOST 106-2320-B-038-061 -MY3 , MOST104-2314-B-038-059-MY3)
This publication has 57 references indexed in Scilit:
- Measuring Activity in the Ubiquitin–Proteasome System: From Large Scale Discoveries to Single Cells AnalysisCell Biochemistry and Biophysics, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Emerging regulatory mechanisms in ubiquitin-dependent cell cycle controlJournal of Cell Science, 2012
- Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivationBreast Cancer Research, 2011
- Regulation of cell death by the ubiquitin–proteasome systemCurrent Opinion in Cell Biology, 2009
- Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating EnzymesAnnual Review of Biochemistry, 2009
- Endocytic Down-Regulation of ErbB2 Is Stimulated by Cleavage of Its C-TerminusMolecular Biology of the Cell, 2007
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerThe New England Journal of Medicine, 2005
- Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific proteaseNature Genetics, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001